Article Details

Janssen Showcases Phase 2 Nipocalimab (M281) Data in Adults with Generalized Myasthenia ...

Retrieved on: 2021-04-16 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Janssen Showcases Phase 2 Nipocalimab (M281) Data in Adults with Generalized Myasthenia .... View article details on hiswai:

Excerpt

Nipocalimab (M281) is a high affinity, fully human, aglycosylated, effectorless IgG1 anti-FcRn monoclonal antibody. In patients with gMG, nipocalimab is ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up